The development of an ovarian follicle requires a complex set of reciprocal interactions between the oocyte and granulosa cells in order for both types of cells to develop properly. These interactions are largely orchestrated by the oocyte via paracrine factors such as growth differentiation factor 9 (GDF9). To examine these interactions further, a study was conducted of the effects of oocytes at different stages of development on proteins synthesized by mouse granulosa cells during the transition of granulosa cells (GCs) from preantral, secondary (2؇) follicles (2؇ GCs) to mural granulosa cells (3؇ GCs) of antral tertiary (3؇) follicles. The ability of recombinant GDF9 to mimic the effects of oocytes was also determined. Effects were evaluated by highresolution, two-dimensional protein gel electrophoresis coupled to computer-assisted, quantitative gel image analysis. Coculture of the 2؇ GCs with growing oocytes (GOs) from 2؇ follicles brought about many of the changes in granulosa cell phenotype associated with the 2؇ to 3؇ follicle transition. GDF9 likewise brought about many of these changes, but only a subset of GDF9-affected protein spots were also affected by coculture with GOs. Coculture of 2؇ GCs with the nearly fully grown oocytes (FGOs) from 3؇ follicles had a reduced effect on 2؇ GC phenotype, in comparison with coculture with GOs. For some proteins, oocyte coculture or GDF9 treatment appeared to have opposite effects on 2؇ GCs and 3؇ GCs. Additional effects of GDF9 and oocytes were seen in cultures of 2؇ GCs for proteins other than those that differed between untreated control 2؇ and 3؇ GCs. These results indicate that GOs and GDF9 can each induce 2؇ GCs to shift their phenotype toward that of 3؇ GCs. The ability of the oocyte to produce this effect is diminished with oocyte development. The transition in the GC phenotype promoted by oocytes appears stable because differences in 2؇ GCs promoted by oocytes and GDF9 were observed in untreated 3؇ GCs. We conclude that the influence of the oocyte on GCs changes with the progression of their development, and so too does the response of the GCs to the oocyte. Moreover, by acting on the 2؇ GCs, GOs are able to influence stably the phenotype of 3؇ GCs. Thus, at or near the 2؇ to 3؇ follicle transition, signals from the growing oocyte contribute to the development of the mural GC phenotype.
INTRODUCTION
The transition from preantral secondary (2Њ) follicle to early antral tertiary (3Њ) follicle is a landmark in follicular development. In 2Њ follicles, two or more layers of granulosa cells (hereafter referred to as 2Њ GCs) surround the growing oocyte (GO). The formation of a follicular antrum, filled with follicular fluid, begins the demarcation of two functionally distinct populations of granulosa cells (GCs) in 3Њ follicles: cumulus cells closely associated with the oocyte and mural GCs (hereafter referred to as 3Њ GCs) lining the follicle wall. The cumulus cells of early 3Њ follicles are able to undergo mucification, or expansion, in vitro when treated with follicle stimulating hormone (FSH) [1] . In mice, the 2Њ to 3Њ follicle transition also coincides with major changes in oocyte development. The GOs in 2Њ follicles are incompetent to resume meiosis when isolated and cultured. In contrast, the nearly fully grown oocytes (FGOs) isolated from 3Њ follicles can resume meiosis and progress to at least metaphase of the first meiotic division (for a review, see [2] ). The expansion of the cumulus oophorus depends on the secretion of one or more factors from the oocyte [3] . However, the ability of the oocyte to enable cumulus expansion is also related to the stage of oocyte and follicular development; only the FGOs competent to resume meiosis after removal from 3Њ follicles and culture can enable cumulus expansion [1, 4] . Oocytes affect the development of GCs in other ways besides enabling cumulus expansion; they affect granulosa cell proliferation, steroidogenesis, and differentiation (for a review, see [3] ).
Growth differentiation factor 9 (GDF9), an oocyte-specific member of the transforming growth factor-␤ superfamily, is produced throughout oocyte development. Follicles fail to develop beyond the primary stage in Gdf9 null mice [5] . Because recombinant GDF9 promotes granulosa cell proliferation and cumulus expansion [6, 7] , it is thought to participate in GC development throughout follicular development. In fact, both FGOs and GDF9 can promote the expression by mural GCs of hyaluronan synthase 2 (Has2), a gene normally expressed by cumulus cells and required for cumulus expansion [6, 8, 9] . The mural GCs of preovulatory follicles express luteinizing hormone/choriogonadotropin receptor (Lhcgr) mRNA, but mouse cumulus cells do not [10, 11] . Oocytes and recombinant GDF9 suppress the expression of Lhcgr mRNA in both cumulus and mural GCs in vitro [6, 11] . Because, in the absence of the oocyte, GCs from antral follicles generally express the mural GC phenotype, it is thought that the default pathway of The vertical arrows indicate the relative magnitude of effects of the indicated treatments on the transition from the 2Њ to 3Њ GC phenotype. Although treatments may have opposing effects on the GC phenotype depending on the stage of GCs that were treated, the transition is relatively stable, as indicated by the lengths of the horizontal arrows.
GC development in the antral follicles of mammalian ovaries leads to the mural GC phenotype. Oocytes can abrogate this default program and promote the expression of the cumulus cell phenotype [3, 12] . However, it is not known whether any aspects of mural GC differentiation might also be influenced by the oocyte. This study used high-resolution, two-dimensional protein gel electrophoresis coupled to computer-assisted, quantitative gel image analysis to compare the effects of oocytes and recombinant GDF9 on the differentiation of GCs during the 2Њ to 3Њ follicle transition. The experimental strategy was to compare the pattern of proteins labeled in vitro with 35 S-methionine in 2Њ GCs isolated from follicles of 12-day-old mice with the pattern of proteins synthesized in mural 3Њ GCs of 16-dayold mice. In addition, these different populations of GCs were cocultured with either GO or FGO isolated from 2Њ or 3Њ follicles, respectively, or with recombinant GDF9. Thus, the stage-specific effects of oocytes or GDF9 on the differentiation of GCs at different stages of their development were evaluated.
MATERIALS AND METHODS

Granulosa Cell Culture and Radiolabeling
Oocytes and GCs were isolated from the ovaries of (C57BL/6J ϫ SJL/ J)F 1 mice. All studies adhered to procedures consistent with the National Research Council Guide for the Care and Use of Laboratory Animals. Preantral GCs (2Њ follicles) of 12-day-old mice ( Fig. 1) were isolated by digestion of the ovary in medium containing 1 mg/ml collagenase and 0.02 mg/ml DNase. Removal of GOs was accomplished by aspirating the preantral granulosa cell-oocyte complexes repeatedly in and out of a borosilicate glass pipet having an internal diameter slightly smaller than the oocyte of 2Њ follicles. Mural GCs (3Њ follicles) of mice 16 days of age were isolated by puncturing the small 3Њ antral follicles with 30-gauge needles and collecting the clumps of mural cells released, avoiding any obviously darkened or degenerating cells. For each experiment, clumps of GCs from fifteen 12-day-old mice or twelve 16-day-old mice were pooled and washed manually by three serial passages using micropipets through dishes of fresh medium and distributed equally to control and experimental groups. The clumps were cultured in 48-well tissue-culture plates containing 150 l medium per well. FGOs were obtained for coculture by puncturing 3Њ follicles of 20-day-old mice with 30-gauge needles, collecting all of the germinal vesicle-stage oocytes released, and stripping any remaining cumulus cells from the oocytes by aspirating them through a narrow-bore pipet. Collection of cells and overnight culture employed Medium 199 (Invitrogen, Carlsbad, CA), which was prepared as described previously [13] and supplemented with 3 mg/ml bovine serum albumin (BSA) and 10 M milrinone (Sigma Chemical Co., St. Louis, MO) to maintain oocytes in meiotic arrest [14] . In coculture groups, GCs were cultured with either 1 FGO/l or 2 GO/l. These concentrations were chosen to be comparable on the basis of oocyte volume [15] . Some cultures of GCs were supplemented with either 25 or 100 g/ml recombinant GDF9 generously provided by Dr. Martin M. Matzuk, Baylor College of Medicine, Houston, TX. All groups of GCs within an experimental replicate, regardless of age, coculture with oocytes, or treatment with GDF9, were cultured at the same time
The GCs of all groups, including control 2Њ and 3Њ GCs, were labeled after 12 h in culture. Oocytes were removed from the coculture groups and the GCs were washed with BSA-free Whitten medium [16] , then incubated with 1 mCi/ml 35 S-methionine (1175 Ci/mmole; DuPont NEN Research Products, Boston, MA) in BSA-free Whitten medium [16] for 3 h. GCs were then lysed in 30 l of hot dSDS solution and heated as described previously [17] [18] [19] . After treatment with DNase and RNase, the lysates were frozen, lyophilized, and redissolved in an equal volume of sample buffer as described previously [17] [18] [19] .
High-Resolution Two-Dimensional Protein Gel Electrophoresis
Isoelectric focusing was performed using approximately 1-2 ϫ 10 6 acid precipitable counts of radiolabeled protein, separated over a pH 3.5-10 gradient. A mixture of 92.5 l Resolyte 3.5-10 (British Drug House, Cater Chemicals, Bensenville, IL), 92.5 l Ampholine 3.5-10 (AmershamPharmacia, Piscataway, NJ), 31 l Servalyt 5-6 (Crescent Chemical, Hauppauge, NY), and 61 l Ampholine 7-9 (Amersham-Pharmacia) was employed to enhance isoelectic focusing. Second dimension gel electrophoresis was performed on 12.5% polyacrylamide gels. Gels were then dried and imaged using a Fuji phosphorimager (Fujifilm, Tokyo, Japan). A total of 37 gels, comprising 2-5 gels representing independent samples for each stage and condition analyzed, were included in the study.
Previous studies have illustrated the value of two-dimensional protein gel image analysis for revealing global patterns of changes in gene expression [19, 20] . Although the identities of all individual protein spots may remain unknown, the ability to resolve and quantify the rates of synthesis of nearly 1000 gene products permits a powerful statistical comparison of samples and permits the creation of sets of valuable molecular markers of cell states and a perspective not readily achieved by alternative means [17, 21, 22] .
Data Analysis
Gel images were processed and analyzed using the PD Quest software package (Bio-Rad Laboratories, Hercules, CA) using procedures employed previously [17, 22, 23] . Spots were detected and quantified using the Gaussian curve-fitting algorithm. Selected spots were matched manually to serve as landmarks for further automated matching. Automated matches were checked manually and inconsistent or partial matches resolved to the greatest extent possible. More than 900 fully matched spots of global quality 50 or greater (a measure of overall spot intensity, focus, and resolution) were successfully matched among the 37 gel images in the set. Phosphorimager values of individual spot intensities were summed for each gel. The individual spot intensities were then normalized to the total for all spots and expressed in units of parts per million (ppm). As with any method that provides for a global analysis of gene expression pattern (e.g., 2D-PAGE, microarrays), it is useful to characterize changes in gene expression by identifying sets of coordinately regulated gene products that change with developmental stage or treatment. To accomplish this, spots representing proteins that displayed statistically significant differences between stages or between treatment conditions were identified using a ttest. This yielded spot sets made of spots that increased or decreased significantly (P Ͻ 0.05) in rates of synthesis either during development or in response to a given treatment. Examination of the numerical degree of spot set overlaps provides one means of evaluating whether different treatments exert similar or distinct effects. Additionally, it is useful to compare effects on spot sets as a whole. To do this, it is necessary to obtain average expression profiles for the different spot sets, which can then be depicted as set graphs. To obtain average expression profiles for spot sets, the mean values of spots for each stage and treatment were determined and then expressed as the percentage of the maximum mean value over the entire range of stages and treatments. These normalized values were then averaged together to yield the average expression profile for each set. Normalizing individual spots to the percentage maximum value avoids disproportionate effects of the most intensely synthesized spots on the average expression profile. The statistical significance of effects of treatments and stage on spot sets was evaluated by applying the paired t-test to spots within the set, the results of which are indicated in the set graphs.
RESULTS
To investigate the controlling mechanisms responsible for GC differentiation, we undertook a global analysis of the effects of oocyte coculture and GDF9 on GC phenotype in vitro by high-resolution two-dimensional PAGE. The relative rates of synthesis of a total of 900 spots were followed through 37 gels. Our analysis revealed significant effects of these treatments on GC phenotype, diagrammed schematically in Figure 1 .
Developmentally Regulated Proteins
As a first step toward evaluating the effects of oocyte coculture and GDF9 treatment on granulosa cell development, we sought to determine whether either treatment affected the expression of developmentally regulated proteins. We first compared 2Њ and 3Њ GCs (Fig. 2) that were cultured for 12 h without either oocytes or GDF9 to identify such proteins. This comparison revealed approximately 48 protein spots (5% of reliably scored spots, 3.3% displaying twofold or greater alterations) that were increased or decreased in intensity between these two stages of GC differentiation ( Fig. 2; Fig. 3, sets A and F; and Fig. 4) . These developmentally regulated sets of proteins provided a start- FIG. 3 . Relationships among developmentally regulated GC proteins and those for which synthesis is affected by treatments of 2Њ GC cultures. Sets A and F are those that differed significantly between untreated 2Њ (12c) and 3Њ (16c) GCs. Sets B-E and G-J are those for which synthesis was reduced or elevated, respectively, in 2Њ GCs by treatment (12c refers to untreated; 12dϩ refers to treated). The numbers of spots in each set are indicated and the numbers of proteins displaying twofold or greater differences in means are shown in parentheses. The numbers over the lines connecting the spot sets indicate overlaps between the sets.
ing point for determining the degree to which oocyte coculture and GDF9 treatments could direct the transition from 2Њ GC to 3Њ GC phenotype in culture.
Effects of Oocyte Coculture and GDF9 Treatment on Developmentally Regulated Proteins
As a set, those proteins for which rates of synthesis declined between 2Њ and 3Њ GCs (set A) showed significantly reduced rates of synthesis in 2Њ GCs cocultured with GOs or FGOs or treated with GDF9 (set A, Fig. 3 ). Synthesis of these proteins, particularly those proteins that were also affected in 2Њ GCs by coculture with GOs or 25 ng/ml GDF9 (A പ B, A പ D) (പ denotes the intersection between sets), tended to increase in synthesis in 3Њ GCs upon treatment with 25 ng/ml GDF9, but not by the other treatments. A larger number of proteins in set A were affected by GOs and 25 ng/ml GDF9 than by FGOs or 100 ng/ml GDF9.
Those proteins that were synthesized at a greater rate in 3Њ GCs than in 2Њ GCs (set F) were significantly elevated in 2Њ GCs cocultured with either GOs or FGOs or treated with either concentration of GDF9 (Fig. 4) . Within set F, some proteins were affected by only a single treatment, whereas others were affected by two or more treatments (Fig. 3) . As with set A, a greater number of set F proteins were affected by GOs and 25 ng/ml GDF9 than were affected by FGOs or 100 ng/ml GDF9 (see set overlaps and graph, Fig. 3 ). Interestingly, synthesis of set F proteins was also slightly, but significantly, reduced in 3Њ GCs treated with GO or GDF9 compared with untreated 3Њ GCs, although this varied among the subsets defined on the basis of statistically significant differences observed with any given treatment (set F, Fig. 4 ).
To summarize the effects of treatments on developmentally regulated proteins, coculture with oocytes or treatment with GDF9 promoted a more mature phenotype in 2Њ GCs resembling the phenotype of mural GCs of 3Њ follicles. GOs FIG. 4 . Set graphs for proteins for which synthetic rates differ between untreated 2Њ (12d) and 3Њ (16d) GCs (sets A and F) and those subsets of proteins for which synthesis is also increased or decreased in 2Њ GCs, by the indicated treatments (പ denotes the intersection between sets). Bars denote the averages of the percent of maximum expression values (as calculated among the 10 means for stage/treatment for each protein individually) for the proteins in the sets. Bars denote values from control and treated 2Њ (12d) and 3Њ (16d) GCs, as indicated. Levels of significance of differences comparing treatments with same-stage untreated GCs only are indicated (a, P Ͻ 0.05; b, P Ͻ 10
Ϫ2
; c, P Ͻ 10 Ϫ3 ; d, P Ͻ 10
Ϫ4
; e, P Ͻ 10 Ϫ5 ). It should be noted that differences were analyzed only for comparisons between treated and untreated GCs within a given stage.
exerted a greater effect than FGOs, and 25 ng/ml GDF9 was more effective than 100 ng/ml. Last, 2Њ GCs and 3Њ GCs displayed in some instances quantitatively opposing responses to some of these treatments (compare, e.g., increased rates of synthesis in treated 2Њ GCs versus untreated 2Њ GCs, as opposed to decreased rates of synthesis in treated 3Њ GCs versus untreated 3Њ GCs in set F, Fig. 4 ).
Broader Effects of Oocyte Coculture and GDF9 Treatment on Protein Synthesis
The data shown in Figures 3 and 4 indicated that not all developmentally regulated proteins were affected by either oocyte coculture or GDF9 treatment, and also that some spots were affected by these treatments but did not differ between untreated 2Њ and 3Њ GCs (i.e., some spots in sets B-F or G-J were not members of sets A or F). This indicated that oocyte coculture or GDF9 might normally support additional developmental transitions beyond those represented by sets A and F alone, and so could not be fully understood by examining only those proteins that differed between untreated 2Њ and 3Њ GCs. To explore more fully the effects of oocyte coculture and GDF9 treatment on GC phenotype, we examined the sets of affected proteins in three ways.
First, we examined effects of treatments on those proteins that displayed increased or decreased rates of synthesis in 2Њ GCs following treatments (sets B-E and sets G-J, Figs. 3 and 5) . Those proteins that were increased in synthesis in 2Њ GCs by any one treatment were also significantly elevated by any of the other three treatments (sets G-J, Fig. 5 ). There was also a statistically significant reduction in synthesis in 3Њ GCs treated with 25 ng/ml GDF9, particularly in set J. Those proteins that were reduced in rates of synthesis in 2Њ GCs by coculture with GOs or treatment with 25 ng/ml GDF9 were likewise reduced by the other three treatments. Based on the sizes (i.e., numbers of members) of the spot sets, treatment with 25 ng/ml GDF9 produced the greatest effect, while FGOs once again produced the smallest effect, as observed for sets A and F above.
Next, we created spot sets on the basis of significant differences within treatment categories but between stages (Fig. 6) . Of the 42 proteins differing between 2Њ and 3Њ GCs cocultured with GO (Fig. 6 , top two panels), 13 were also significantly different when comparing 2Њ and 3Њ GCs not cocultured with GOs. Of the 45 proteins differing between 2Њ and 3Њ GCs cocultured with FGOs, only 9 were also significantly different when comparing 2Њ and 3Њ GCs not cocultured with FGOs. This indicates that certain GC proteins differed between developmental stages when the GCs were cocultured with oocytes, but not in the absence of oocytes. Omitting those proteins that were different when comparing 2Њ and 3Њ GCs not cocultured with oocytes (i.e., subtracting sets A and F from the treated sets), it became apparent that coculture with either GOs or FGOs could exert opposite effects on 2Њ versus 3Њ GCs, see sets Fig. 6 ; a similar trend was apparent in those proteins for which expression increased in the presence of oocytes, i.e., [(L)Ϫ(A)] and [(N)Ϫ(A)], but this did not reach the level of statistical significance. Interestingly, sets of proteins that differed between stage and within treatment were not seen for either 25 ng/ml or 100 ng/ml GDF9 treatment. This indicated that oocyte coculture may be permissive for some developmentally regulated changes in gene expression for which GDF9 is not permissive. It was also noted that only one protein spot was found shared between sets [(K)Ϫ( Last, we examined the effects of each of the four treatments on 3Њ GCs (Fig. 7) . The sizes of these spot sets were smaller than those observed in 2Њ GCs. Interestingly, coculture with FGOs affected more spots in 3Њ GCs than in Figs. 3 and 7) . There appeared to be a greater degree of independence in responses of 3Њ GCs to the different treatments, as indicated by the reduced frequency of proteins for which synthesis was affected by more than one treatment.
2Њ GCs (compare
Relationship Between Developmental Regulation and Response to Treatment
The examination of developmentally regulated proteins (sets A-J) indicated that each of the four treatments, and particularly coculture with GOs and 25 ng/ml GDF9, could exert opposite effects on the rates of synthesis of affected proteins in 2Њ GCs as compared with 3Њ GCs. To explore this relationship further, we examined those subsets of proteins that were significantly altered by each treatment when compared with untreated cultures of the same stage but that did not differ significantly between untreated 2Њ and 3Њ GCs (Fig. 8) . The tendency for opposing effects was not apparent among these proteins. Thus, the opposing effects of treatments on 2Њ versus 3Њ GCs appear to be restricted to the developmentally regulated proteins.
DISCUSSION
The development of 2Њ GCs to 3Њ GCs is reflected in either increases or decreases in the rates of synthesis of specific proteins representing approximately 5% of the total number of proteins that could be reliably scored in this study, with 3.3% displaying twofold or greater alterations. Analysis of the effects of GOs, FGOs, and GDF9 on the rates of synthesis of these proteins thus provides insight into how the oocyte affects GC development, how signals emanating from the oocyte change during folliculogenesis, how the response of GCs to the oocyte factors also changes, and to what degree oocyte effects on GCs are attributable to GDF9 alone.
Coculture of 2Њ GCs with GOs or treatment with GDF9 promoted many of the changes exhibited during the transition to 3Њ GCs. Moreover, these changes were stable; i.e., the changes in 2Њ GCs promoted by coculture with GO or treatment with GDF9 were expressed by 3Њ GCs without oocytes or GDF9. Additionally, the effects of GOs on the transition from the 2Њ GCs to 3Њ GCs appear to be mediated, to a significant extent, by GDF9. Coculture of 2Њ GCs with FGOs did not promote the same changes in protein syn- thetic patterns as did coculture with GOs. Because the effects of FGOs on 2Њ GCs are reduced compared with those of GOs and GDF9, it can be inferred that FGOs and GOs either secrete different amounts of GDF9, with an accompanying difference in GC response, or that other factors that mitigate the effects of GDF9 are also secreted by FGOs.
The ability of GOs to induce 2Њ GCs to adopt characteristics of 3Њ GCs implicates the oocyte in an early step in the process of mural granulosa cell differentiation. It has been proposed that the default pathway of granulosa cell differentiation is that leading to the mural GCs, but that oocytes can abrogate the default pathway and promote differentiation to the cumulus cell phenotype [3, 12] . This hypothesis was based on evidence that the oocyte prevents the expression of Lhcg mRNA and can account for the observation that mural GCs, but not cumulus cells, of large antral follicles express this transcript [11, 24] . However, the results presented here reveal a more pervasive, previously unappreciated, effect of the oocyte on the development of the mural granulosa cell phenotype. These results indicate that some aspects of this phenotype are stably programmed by paracrine factors produced by the oocyte during the 2Њ to 3Њ transition. Moreover, one oocyte-derived paracrine factor contributing to this programming is GDF9.
It does not appear, however, that FGOs lose all ability to affect GC function, as the FGOs exerted a more pronounced effect on the 3Њ GC phenotype than did the GOs. This indicates that the array of signals emanating from the oocyte changes during the 2Њ to 3Њ transition, and that the mural GCs therefore continue to respond to oocyte-derived signals even at the 3Њ stage and despite the increased distance between the oocyte and mural GCs.
Just as the signals produced by the oocytes change between the 2Њ and 3Њ stages, so does the response of the GCs to those signals. This was evident not only in the greater response of 3Њ GCs than of 2Њ GCs to FGOs, but also in the opposing effects of GOs and of GDF9 on 2Њ versus 3Њ GCs. Based on these opposing effects, it is clear that the actions of oocytes and the responses of GCs to them are both developmentally regulated. This was also observed in the regulation of Kitl mRNA expression in GCs by oocytes and GDF9. GOs had a slightly positive effect on Kitl ex-FIG. 8. Set graphs for those proteins that are affected by the four treatments in 2Њ GCs but that do not differ significantly between untreated 2Њ GCs and 3Њ GCs. Graphs and levels of significance are as shown for Figure 4. pression by 2Њ GCs. In contrast, FGOs strongly suppressed Kitl expression by both 2Њ and 3Њ GCs (both mural and cumulus GCs) [25, 26] . The effects of recombinant GDF9 on Kitl expression in 2Њ and 3Њ GCs were essentially the same as those of FGOs, but not of GOs [25, 26] . The differing activities of oocytes and responsiveness of GCs at different developmental stages are also illustrated by the mitogenic activity of GOs and FGOs. FGOs stimulate the proliferation of both 3Њ and 2Њ GCs, but GOs have little mitogenic effect on GCs of either developmental stage [27, 28] .
Differing responses of GCs at different stages of their development could be explained by several different potential mechanisms, hypothesis of which, at this point, would be highly speculative. The differing actions of oocytes at different stages of development suggest either that they secrete multiple ligands or that they somehow modulate the effect of a single ligand. Although GDF9 appeared to have effects similar to those of GOs on protein synthetic patterns in GCs, they were not identical. Taken together, these considerations strongly suggest that multiple oocyte-derived paracrine factors and potential modulators promote different aspects of granulosa cell differentiation. It is also important to consider whether the denuded oocytes used in these experiments produce or secrete these factors similarly to oocytes in situ. GCs could modify these functions of oocytes via membrane contact or gap junction-mediated mechanisms, and some signals may be transmitted via gap junctions or direct cell contact.
Mouse oocytes transferred from 2Њ follicles to primordial follicles essentially doubled the rate of follicular development [29] . In addition to an increase in the rate of formation of antral follicles, this transfer promoted precocious differentiation of GCs exhibiting functional and molecular characteristics appropriate to both the cumulus and mural granulosa cell phenotypes [29] . The finding reported here that the oocyte exerts advance programming of mural granulosa cell differentiation at the 2Њ to 3Њ follicle transition, and thus regulates the developmental pathway of cells that no longer are in close association with the oocyte at a later stage, may help explain this precocious differentiation of the mural GCs. Moreover, the present findings reveal a heretofore unexpected complexity in the interactions between oocytes and the entire follicular complement of GCs during folliculogenesis and oogenesis.
